natgillin/translations-raw huggingface dataset:
After intramuscular (IM) injection of cefuroxime to normal volunteers, the mean peak serum concentrations ranged from 27 to 35 µg/mL for a 750 mg dose and from 33 to 40 µg/mL for a 1000 mg dose, and were achieved within 30 to 60 minutes after administration.
injiciranju cefuroksima zdravim prostovoljcem je povprečna največja koncentracija v serumu segala od 27 do 35 µg/ml z odmerkom 750 mg in od 33 do 40 µg/ml z odmerkom 1000 mg; dosežena je bila v 30 do 60 minutah po uporabi.
MARKETING AUTHORISATION NUMBER(S) [To be completed nationally]
ŠTEVILKA(E) DOVOLJENJA (DOVOLJENJ) ZA PROMET <[izpolni država članica]>
750 mg every 6 hours (intravenously) 1.5 g every 8 hours (intravenously)
750 mg na 6 ur (intravensko) 1,5 g na 8 ur (intravensko)
• reduced affinity of penicillin-binding proteins for cefuroxime;
• zmanjšane afinitete beljakovin, ki vežejo peniciline, za cefuroksim;
The serum half-life after either intramuscular or intravenous injection is approximately 70 minutes.
Serumski razpolovni čas je približno 70 minut tako po intramuskularnem kot intravenskem injiciranju.
Recommended doses for Zinacef in renal impairment
Priporočeni odmerki zdravila Zinacef pri okvari ledvic
cardiovascular, and gynaecological surgery (including caesarean section).
kardiovaskularnih in ginekoloških operacijah (vključno s carskim rezom).
With the vial uppermost, transfer the reconstituted cefuroxime sodium into the infusion bag by squeezing and releasing the bag.
Z zgornjim delom viale prenesite pripravljeni natrijev cefuroksimat v infuzijsko vrečko tako, da vrečko stiskate in spuščate.
Gram-negative anaerobes:
Po Gramu negativni anaerobi:
Belgium, Bulgaria, Cyprus, Czech Republic, Denmark , Estonia, Finland, Greece, Hungry, Iceland, Ireland, Lithuania, Luxembourg, Netherlands, Norway, Poland, Romania, Slovenia, Sweden, United Kingdom - Zinacef
Belgija, Bolgarija, Ciper, Češka, Danska, Estonija, Finska, Grčija Madžarska, Islandija, Irska, Litva, Luksemburg, Nizozemska, Norveška, Poljska, Romunija, Slovenija, Švedska, Združeno kraljestvoZinacef
6 mL at least 15mL 15 mL*
6 ml vsaj 15 ml 15 ml*
Gram-positive anaerobes:
Po Gramu pozitivni anaerobi:
There is an almost complete recovery (85 to 90%) of unchanged cefuroxime in urine within 24 hours of administration.
V 24-ih urah po prejemu odmerka se cefuroksim skoraj v celoti (85-90 %) izloči z urinom v nespremenjeni obliki.
PHARMACEUTICAL FORM AND CONTENTS [To be completed nationally]
FARMACEVTSKA OBLIKA IN VSEBINA [izpolni država članica]
Cefuroxime is effectively removed by haemodialysis and peritoneal dialysis.
Cefuroksim se učinkovito odstrani s hemodializo in peritonealno dializo.
750 mg every 8 hours (intravenously or intramuscularly)
750 mg na 8 ur (intravensko ali intramuskularno)
High-dosage treatments with cephalosporins should be carried out with caution on patients who are taking strong-acting diuretics (such as furosemide) or potential nephrotoxic preparations (such as aminoglycoside antibiotics), since impairment of renal function through such combinations cannot be ruled out.
Potencialno nefrotoksična zdravila in diuretiki zanke Pri bolnikih, ki se zdravijo z močnimi diuretiki, (npr. furosemidom) ali potencialno nefrotoksičnimi učinkovinami (npr. aminoglikozidnimi antibiotiki), je potrebna previdnost pri dajanju visokih odmerkov cefalosporinskih antibiotikov, saj pri tovrstnih kombinacijah ni mogoče izključiti možnosti za okvaro ledvic.
• injection site pain, swelling and redness along a vein.
• bolečina na mestu injiciranja, oteklost in pordelost vzdolž vene.
Addition volumes and solution concentrations, which may be useful when fractional doses are required.
Dodane količine in koncentracije raztopin, ki so lahko uporabne, če so potrebni frakcijski odmerki.
Addition volumes and solution concentrations, which may be useful when fractional doses are required
Dodane količine in koncentracije raztopin, ki so lahko uporabne, če so potrebni frakcijski odmerki
It will retain potency for up to 24 hours at room temperature in:
Pri sobni temperaturi se bo njegova učinkovitost ohranila do 24 ur, če ga dodamo:
Non-clinical data reveal no special hazard for humans based on conventional studies of safety pharmacology, repeated dose toxicity, genotoxicity and toxicity to reproduction and development.
Predklinični podatki na osnovi običajnih študij farmakološke varnosti, toksičnosti pri ponavljajočih odmerkih, genotoksičnosti in vpliva na sposobnost razmnoževanja in razvoja ne kažejo posebnega tveganja za človeka.
• skin rash, which may blister, and looks like small targets (central dark spot surrounded by a paler area, with a dark ring around the edge) erythema multiformae.
• izpuščaj na koži, ki je lahko mehurjast in na pogled podoben majhnim tarčam (temna osrednja pika, obdana z bledim kolobarjem in temnim obročem ob robu) - multiformni eritem.
• diarrhoea, nausea, stomach pain
• driska, slabost v želodcu, bolečina v želodcu.
Surgical prophylaxis for gastrointestinal, gynaecological surgery (including caesarean section) and orthopaedic operations
kirurška profilaksa pri operacijah prebavil, ginekoloških (vključno s carskim rezom) in ortopedskih operacijah
1 mL at least 2 mL
1 ml vsaj 2 ml
Adults and adolescents 750 mg to 1.5 g of Zinacef per day divided into two, three or four doses.
Od 750 mg do 1,5 g zdravila Zinacef na dan, razdeljeno na dva, tri ali štiri odmerke.
To activate, push the plastic needle holder of the Monovial down onto the vial shoulder until a
Za aktivacijo potisnite plastično držalo igle monoviale navzdol, proti ovratnemu delu viale,
• the lungs or chest
• pljuč ali prsnega koša;
Cefuroxime has been shown to cross the placenta and attain therapeutic levels in amniotic fluid and cord blood after intramuscular or intravenous dose to the mother.
Dokazano je, da cefuroksim po intramuskularnem ali intravenskem apliciranju materi prehaja skozi placento in v amnijski tekočini ter popkovnični krvi doseže terapevtske koncentracije.
History of severe hypersensitivity (e.g. anaphylactic reaction) to any other type of beta-lactam antibacterial agent (penicillins, monobactams and carbapenems).
Anamneza hude preobčutljivosti (npr. anafilaktične reakcije) na katero koli vrsto betalaktamskih protibakterijskih zdravil (peniciline, monobaktame ali karbapeneme).
Gram-negative aerobes:
Po Gramu negativni aerobi:
Candida overgrowth, overgrowth of Clostridium difficile
Infekcijske in parazitske bolezni razrast kandide, razrast Clostridium difficile
Gamma glutamyl transpeptidase activity in rat urine is inhibited by various cephalosporins, however the level of inhibition is less with cefuroxime.
Različni cefalosporini zavirajo aktivnost gama-glutamiltranspeptidaze v podganjem urinu, vendar je izrazitost zavrtja s cefuroksimom manjša.
5% Dextrose Injection BP
5 % raztopini glukoze za injiciranje (BP);
- If you get any side effects, talk to your doctor or nurse.
- Če opazite kateri koli neželeni učinek, se posvetujte s svojim zdravnikom, ali z medicinsko sestro.
1.5 g Monovial powder for solution for infusion Belgium, Luxembourg - Zinacef Italy - Curoxim
1,5 g prašek za raztopino za infundiranje, monoviala Belgija, Luksemburg - Zinacef Italija - Curoxim
• fungal infections
• glivične okužbe;
Shake the vial to reconstitute the cefuroxime sodium.
Pretresite vialo, da boste pripravili natrijev cefuroksimat.
What Zinacef contains
Kaj vsebuje zdravilo Zinacef
• skin rash, which may blister, and looks like small targets (central dark spot surrounded by a paler area, with a dark ring around the edge).
• izpuščaj na koži, ki lahko oblikuje mehurje in daje videz majhnih tarč (temnih osrednjih točk, ki jih obdaja svetlejši predel, obdan s temnim robom).
Side effects that may show up in blood tests:
Neželeni učinki, ki se lahko pokažejo pri preiskavah krvi:
Cefuroxime is not metabolised.
Cefuroksim se ne presnavlja.
You may need extra check-ups to monitor your renal function while you are taking Zinacef.
Morda boste med zdravljenjem z zdravilom Zinacef potrebovali dodatne kontrole za spremljanje delovanja ledvic.
Gram-positive aerobes:
Po Gramu pozitivni aerobi:
DATE OF REVISION OF THE TEXT [To be completed nationally]
DATUM ZADNJE REVIZIJE BESEDILA {MM/ YYYY} [izpolni država članica]
2 g powder for solution for infusion 2 g intravenous infusion
2 g prašek za raztopino za infundiranje 2 g intravenska infuzija
• Prophylaxis against infection in gastrointestinal (including oesophageal), orthopaedic,
• profilaksa okužb pri operacijah prebavil (vključno z operacijami požiralnika), ortopedskih,
Immune system disorders drug fever, interstitial nephritis, anaphylaxis, cutaneous vasculitis
Bolezni imunskega sistema povišana telesna temperatura zaradi zdravljenja z zdravilom (t. i. drug fever), intersticijski nefritis, anafilaksija, kožni vaskulitis
However, in older infants (aged >3 weeks) and in children, the serum half-life of 60 to 90 minutes is similar to that observed in adults.
Ugotovljeno je, da je serumski razpolovni čas cefuroksima pri novorojenčkih bistveno podaljšan glede na gestacijsko starost, vendar je pri starejših dojenčkih (starih več kot 3 tedne) in otrocih serumski razpolovni čas podoben kot pri odraslih in znaša od 60 do 90 minut.
Preparation of solution for intravenous infusion The contents of the Monovial are added to small volume infusion bags containing 0.9% Sodium Chloride Injection, or 5% Dextrose Injection, or another compatible fluid.
Priprava raztopine za intravensko infundiranje Vsebino monoviale je treba dodati v infuzijske vrečke majhne prostornine, ki vsebujejo 0,9 % raztopino natrijevega klorida za injiciranje, 5 % raztopino glukoze za injiciranje ali drugo kompatibilno tekočino.
Zinacef powder for solution for injection and infusion contains sodium.
Zinacef prašek za raztopino za injiciranje in infundiranje vsebuje natrij.
The contents of the Monovial are added to small volume infusion bags containing 0.9% Sodium Chloride Injection, or 5% Dextrose Injection, or another compatible fluid.
Vsebino monoviale je treba dodati v infuzijske vrečke majhne prostornine, ki vsebujejo 0,9 % raztopino natrijevega klorida za injiciranje, 5 % raztopino glukoze za injiciranje ali drugo kompatibilno tekočino.
For every 1 kg the baby or child weighs, they'll be given 30 to 100 mg of Zinacef per day divided in three or four doses.
Dojenček oziroma otrok bo dobil od 30 do 100 mg zdravila Zinacef na kilogram telesne mase na dan, razdeljeno na tri ali štiri odmerke.
How to store Zinacef
Kako uporabljati zdravilo Zinacef
1 g powder for solution for injection 1 g intramuscular intravenous bolus
1 g prašek za raztopino za injiciranje 1 g intramuskularno intravenski bolus
In patients with hepatic dysfunction this is not expected to effect the pharmacokinetics of cefuroxime.
Ni pričakovati, da bi moteno delovanje jeter vplivalo na farmakokinetiko cefuroksima.
Complicated urinary tract infections, including pyelonephritis
zapletene okužbe sečil, vključno s pielonefritisom
<{fax}> <{e-mail}>
{DD. mesec YYYY}
Cefuroxime is primarily excreted by the kidneys.
Cefuroksim se izloča predvsem skozi ledvice.
How to store Zinacef [To be completed nationally] Keep this medicine out of the sight and reach of children.
Shranjevanje zdravila Zinacef [izpolni država članica] Zdravilo shranjujte nedosegljivo otrokom!
Zinacef is also used:
Zdravilo Zinacef se uporablja tudi za:
Preparation of solution for intravenous infusion
Priprava raztopine za intravensko infundiranje
As a false negative result may occur in the ferricyanide test, it is recommended that either the glucose oxidase or hexokinase methods are used to determine blood/plasma glucose levels in patients receiving cefuroxime sodium.
Za določevanje glukoze v krvi/plazmi bolnikov, ki prejemajo natrijev cefuroksimat, je priporočljivo uporabljati glukoza oksidazno ali heksokinazno metodo.
Hepatobiliary disorders transient rise in liver enzymes transient rise in bilirubin
Bolezni jeter, žolčnika in žolčevodov prehodno povečane vrednosti jetrnih encimov prehodno povečane vrednosti bilirubina
Uncommon side effects that may show up in blood tests:
Občasni neželeni učinki, ki se lahko pokažejo pri preiskavah krvi:
As with all beta-lactam antibacterial agents, serious and occasionally fatal hypersensitivity reactions have been reported.
Opisane so bile resne in občasno smrtne preobčutljivostne reakcije, tako kot pri vseh betalaktamskih protibakterijskih zdravilih.
1.5 g powder for solution for injection or infusion 1.5 g intramuscular intravenous bolus intravenous infusion
1,5 g prašek za raztopino za injiciranje ali infundiranje 1,5 g intramuskularno intravenski bolus intravenska infuzija
750 mg powder for solution for injection or infusion 750 mg intramuscular intravenous bolus intravenous infusion
750 mg prašek za raztopino za injiciranje ali infundiranje 750 mg intramuskularno intravenski bolus intravenska infuzija
Gastrointestinal disorders gastrointestinal disturbance pseudomembranous colitis
Bolezni prebavil gastrointestinalne motnje psevdomembranozni kolitis
500 mg powder for solution for injection 500 mg intramuscular
500 mg prašek za raztopino za injiciranje 500 mg intramuskularno
250 mg powder for solution for injection
250 mg prašek za raztopino za injiciranje
• Complicated urinary tract infections, including pyelonephritis.
• zapletene okužb sečil, vključno s pielonefritisom;
Cefuroxime sodium (5 mg/ml) in 5% w/v or 10% w/v xylitol injection may be stored for up to 24 h at 25oC.
Natrijev cefuroksimat (5 mg/ml) lahko v 5 % m/V ali 10 % m/V raztopini ksilitola za injiciranje shranjujemo do 24 ur pri temperaturi 25oC.
You must look out for certain symptoms such as allergic reactions and gastrointestinal disorders such as diarrhoea while you are being given Zinacef.
Med prejemanjem zdravila Zinacef morate biti pozorni na določene simptome, npr. na alergijske reakcije in na prebavne motnje, kakršna je driska.
At least 6 mL At least 6 mL
3 ml vsaj 6 ml vsaj 6 ml
Your doctor or nurse will dispose of any medicine that is no longer required.
O načinu odstranjevanja zdravila, ki ga ne uporabljate več, se posvetujte s farmacevtom.
General disorders and administration site conditions injection site reactions which may include pain and thrombophlebitis Description of selected adverse reactions Cephalosporins as a class tend to be absorbed onto the surface of red cell membranes and react with antibodies directed against the drug to produce a positive Coomb's test (which can interfere with cross matching of blood) and very rarely haemolytic anaemia.
Splošne težave in spremembe na mestu aplikacije reakcije na mestu injiciranja, ki lahko vključujejo bolečine in tromboflebitis Opis izbranih neželenih učinkov Antibiotiki iz skupine cefalosporinov imajo tendenco adsorpcije na membrane eritrocitov in reagiranja s protitelesi proti zdravilu.
PHARMACEUTICAL PARTICULARS 6.1 List of excipients [To be completed nationally] 6.2 Incompatibilities [To be completed nationally] 6.3 Shelf life
6.2 Inkompatibilnosti [izpolni država članica] 6.3 Rok uporabnosti [izpolni država članica]
750 mg powder for solution for injection or infusion Austria - Curocef
750 mg prašek za raztopino za injiciranje ali infundiranje Avstrija - Curocef
Zinacef and associated names (see Annex I) 250 mg powder for solution for injection Zinacef and associated names (see Annex I) 750 mg powder for solution for injection Zinacef and associated names (see Annex I) 1.5 g powder for solution for injection Zinacef and associated names (see Annex I) 250 mg powder and solvent for solution for injection Zinacef and associated names (see Annex I) 500 mg powder and solvent for solution for injection Zinacef and associated names (see Annex I) 750 mg powder and solvent for solution for injection Zinacef and associated names (see Annex I) 1 g powder and solvent for solution for injection Zinacef and associated names (see Annex I) 750 mg powder for solution for infusion Zinacef and associated names (see Annex I) 1.5 g powder for solution for infusion Zinacef and associated names (see Annex I) 2 g powder for solution for infusion Zinacef and associated names (see Annex I) 250 mg powder for solution for injection or infusion Zinacef and associated names (see Annex I) 750 mg powder for solution for injection or infusion Zinacef and associated names (see Annex I) 1.5 g powder for solution for injection or infusion Zinacef and associated names (see Annex I) 750 mg powder for solution for infusion (Monovial presentation) Zinacef and associated names (see Annex I) 1.5 g powder for solution for infusion (Monovial presentation)
Zinacef in povezana imena (glejte Prilogo I) 250 mg prašek za raztopino za injiciranje Zinacef in povezana imena (glejte Prilogo I) 750 mg prašek za raztopino za injiciranje Zinacef in povezana imena (glejte Prilogo I) 1,5 g prašek za raztopino za injiciranje Zinacef in povezana imena (glejte Prilogo I) 250 mg prašek in vehikel za raztopino za injiciranje Zinacef in povezana imena (glejte Prilogo I) 500 mg prašek in vehikel za raztopino za injiciranje Zinacef in povezana imena (glejte Prilogo I) 750 mg prašek in vehikel za raztopino za injiciranje Zinacef in povezana imena (glejte Prilogo I) 1 g prašek in vehikel za raztopino za injiciranje Zinacef in povezana imena (glejte Prilogo I) 750 mg prašek za raztopino za infundiranje Zinacef in povezana imena (glejte Prilogo I) 1,5 g prašek za raztopino za infundiranje Zinacef in povezana imena (glejte Prilogo I) 2 g prašek za raztopino za infundiranje Zinacef in povezana imena (glejte Prilogo I) 250 mg prašek za raztopino za injiciranje ali infundiranje Zinacef in povezana imena (glejte Prilogo I) 750 mg prašek za raztopino za injiciranje ali infundiranje Zinacef in povezana imena (glejte Prilogo I) 1,5 g prašek za raztopino za injiciranje ali infundiranje Zinacef in povezana imena (glejte Prilogo I) 750 mg prašek za raztopino za infundiranje (monoviala) Zinacef in povezana imena (glejte Prilogo I) 1,5 g prašek za raztopino za infundiranje (monoviala)
T1/2 (hrs)
Očistek kreatinina t1/2 (ure)
For every 1 kg the baby weighs, they'll be given 30 to 100 mg Zinacef per day divided in two or three doses.
Dojenček bo dobil od 30 do 100 mg zdravila Zinacef na kilogram telesne mase na dan, razdeljeno na dva ali tri odmerke.
Pain at the intramuscular injection site is more likely at higher doses.
Verjetneje je, da se bo bolečina na mestu intramuskularnega injiciranja pojavila pri višjih odmerkih, vendar pa je malo verjetno, da bo zaradi bolečine zdravljenje potrebno opustiti.
Amount of sodium per vial
Količina natrija na vialo
Zinacef and associated names (see Annex I) 750 mg powder for solution for injection Zinacef and associated names (see Annex I) 1.5 g powder for solution for injection Zinacef and associated names (see Annex I) 250 mg powder and solvent for solution for injection Zinacef and associated names (see Annex I) 500 mg powder and solvent for solution for injection Zinacef and associated names (see Annex I) 750 mg powder and solvent for solution for injection Zinacef and associated names (see Annex I) 1 g powder and solvent for solution for injection Zinacef and associated names (see Annex I) 750 mg powder for solution for infusion Zinacef and associated names (see Annex I) 1.5 g powder for solution for infusion Zinacef and associated names (see Annex I) 2 g powder for solution for infusion Zinacef and associated names (see Annex I) 250 mg powder for solution for injection or infusion Zinacef and associated names (see Annex I) 750 mg powder for solution for injection or infusion Zinacef and associated names (see Annex I) 1.5 g powder for solution for injection or infusion Zinacef and associated names (see Annex I) 750 mg powder for solution for infusion (Monovial presentation)
Zinacef in povezana imena (glejte Prilogo I) 750 mg prašek za raztopino za injiciranje Zinacef in povezana imena (glejte Prilogo I) 1,5 g prašek za raztopino za injiciranje Zinacef in povezana imena (glejte Prilogo I) 250 mg prašek in vehikel za raztopino za injiciranje Zinacef in povezana imena (glejte Prilogo I) 500 mg prašek in vehikel za raztopino za injiciranje Zinacef in povezana imena (glejte Prilogo I) 750 mg prašek in vehikel za raztopino za injiciranje Zinacef in povezana imena (glejte Prilogo I) 1 g prašek in vehikel za raztopino za injiciranje Zinacef in povezana imena (glejte Prilogo I) 750 mg prašek za raztopino za infundiranje Zinacef in povezana imena (glejte Prilogo I) 1,5 g prašek za raztopino za infundiranje Zinacef in povezana imena (glejte Prilogo I) 2 g prašek za raztopino za infundiranje Zinacef in povezana imena (glejte Prilogo I) 250 mg prašek za raztopino za injiciranje ali infundiranje Zinacef in povezana imena (glejte Prilogo I) 750 mg prašek za raztopino za injiciranje ali infundiranje Zinacef in povezana imena (glejte Prilogo I) 1,5 g prašek za raztopino za injiciranje ali infundiranje Zinacef in povezana imena (glejte Prilogo I) 750 mg prašek za raztopino za infundiranje (monoviala) Zinacef in povezana imena (glejte Prilogo I) 1,5 g prašek za raztopino za infundiranje (monoviala)
250 mg powder for solution for injection 250 mg intramuscular intravenous
250 mg prašek za raztopino za injiciranje 250 mg intramuskularno intravensko
500 mg powder for solution for injection Italy - Curoxim
500 mg prašek za raztopino za injiciranje Italija - Curoxim
The stability of cefuroxime sodium in Sodium Chloride Injection BP 0.9% w/v and in 5% Dextrose Injection is not affected by the presence of hydrocortisone sodium phosphate.
Prisotnost hidrokortizon-natrijevega fosfata ne vpliva na stabilnost natrijevega cefuroksimata v 0,9 % m/V raztopini natrijevega klorida za injiciranje (BP) in 5 % raztopini glukoze za injiciranje.
Antibacterial agent-associated pseudomembranous colitis has been reported with use of cefuroxime and may range in severity from mild to life threatening.
Med uporabo cefuroksima je bil opisan psevdomembranozni kolitis, povezan s protibakterijskimi zdravili; po izrazitosti lahko sega od blagega do smrtno nevarnega.
1.5 g cefuroxime sodium constituted with 15 mL Water for Injection may be added to metronidazole injection (500 mg/100 ml) and both retain their activity for up to 24 hours below 25 oC. 1.5 g cefuroxime sodium is compatible with azlocillin 1 g (in 15 ml) or 5 g (in 50 ml) for up to 24 h at 4oC or 6 h below 25oC.
1,5 g natrijevega cefuroksimata je kompatibilno z 1 g azlocilina (v 15 ml) ali 5 g azlocilina (v 50 ml), in sicer: do 24 ur pri temperaturi 4°C ali 6 ur pri temperaturi do 25°C.
Concentrations of cefuroxime in excess of the minimum inhibitory levels for common pathogens can be achieved in the tonsilla, sinus tissues, bronchial mucosa, bone, pleural fluid, joint fluid, synovial fluid, interstitial fluid, bile, sputum and aqueous humour.
Povprečen volumen porazdelitve po intramuskularni ali intravenski uporabi odmerkov v razponu od 250 do 1000 mg sega od 9,3 do 15,8 l/1,73 m2. Koncentracije cefuroksima, ki presegajo minimalno inhibitorno koncentracijo za običajne patogene, je mogoče doseči v mandljih, sinusnih tkivih, bronhialni sluznici, kosteh, plevralni tekočini, sklepni tekočini, sinovijski tekočini, intersticijski tekočini, žolču, sputumu in očesni vodici.
1 g powder for solution for injection or infusion Italy - Curoxim
1 g prašek za raztopino za injiciranje ali infundiranje Italija - Curoxim
2 g powder for solution for infusion Italy - Curoxim
2 g prašek za raztopino za infundiranje Italija - Curoxim
Complicated urinary tract infections, including pyelonephritis Soft-tissue infections: cellulitis, erysipelas and wound infections
Odmerek pljučnica, dobljena v domačem okolju, in akutno poslabšanje kroničnega bronhitisa okužbe mehkih tkiv: celulitis, erizipel in okužbe ran intraabdominalne okužbe
Renal function should be monitored in the elderly and those with known pre-existing renal impairment (see section 4.2).
Pri starostnikih in bolnikih, ki že imajo okvaro ledvic, je potrebno spremljanje delovanja ledvic (glejte poglavje 4.2).
Streptococcus mitis (viridans group)
Streptococcus mitis (skupina viridans) Po Gramu negativni aerobi:
There was no evidence of accumulation of cefuroxime in the serum from normal volunteers following repeat intravenous administration of 1500 mg doses every 8 hours.
Po ponavljajoči se intravenski uporabi 1500-mg odmerkov na 8 ur v serumu zdravih prostovoljcev niso odkrili znakov kopičenja cefuroksima.